drugset / Trial / NCT00592111
A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)
Phase 2
Completed
21 enrolled
Memorial Sloan Kettering Cancer Center
Children's Cancer Group · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Study Hypothesis: Clinical staging without laparotomy/splenectomy is adequate for children and young adults with Hodgkin's disease who receive chemotherapy as a component of treatment.
Timeline
- Start
- 1996-03
- Primary completion
- 1999-02
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bleomycin | Unknown | — | — |
| Subject | Cyclophosphamide | Other / unclassified | — | — |
| Subject | Cytarabine | Small molecule | — | — |
| Subject | Doxorubicin | Other / unclassified | — | — |
| Subject | Etoposide | Small molecule | — | — |
| Subject | Prednisone | Other / unclassified | — | — |
| Subject | Vinblastine | Small molecule | — | — |
| Subject | Vincristine | Small molecule | — | — |
| Subject | filgrastim | Protein / enzyme biologic | — | — |
| Subject | procarbazine | Small molecule | — | — |